Surgical Sponges Market by Type (Laparotomy Sponges, Cotton Gauze), Material (Cotton, Rayon, PVA), Shape (Square, Rectangle), Sterility (Sterile, Non-sterile), Application (Neurosurgery, Laparotomy, ENT, General Surgery) - Global Forecast to 2029
세계 수술용 스펀지 시장 규모는 2024년 8억 1,000만 달러에 달할 것으로 예상되며, 예측 기간 중 CAGR은 7.9%로 전망되고 있으며, 2029년에는 11억 9,000만 달러에 달할 것으로 예측됩니다.
외상 사례와 사고 증가, 건강 관리 인프라 개척이 수술용 스펀지 시장 성장의 주요 촉진요인입니다. 무균 수술용 스펀지 및 기타 유용한 수술 용품은 외상 및 사고와 관련된 치료의 빈도가 증가함에 따라 점점 더 필요해지고 있습니다. 따라서 외상이나 사고가 만연하면 수술용 스펀지의 요구가 높아질 가능성이 높습니다.
| 조사 범위 |
| 조사 대상년도 |
2022-2029년 |
| 기준년 |
2023년 |
| 예측 기간 |
2024-2029년 |
| 검토 단위 |
금액(10억 달러) |
| 부문 |
유형별, 소재별, 형상별, 무균성별, 용도별, 최종 사용자별, 지역별 |
| 대상 지역 |
북미, 유럽, 아시아태평양, 중동, 아프리카, 라틴아메리카, GCC 국가 |
유형별로, 수술용 스펀지 시장은 X선 검출가능 스펀지, 면 거즈 스펀지, 개복용 스펀지, 부직포 스펀지 및 기타 수술용 스펀지로 구분됩니다. X선 검출가능 스펀지는 외과 수술 중 수술용 스펀지와 같은 외과 용품의 잔여물을 확인하여 잔여 위험을 줄이고 환자의 안전성을 크게 향상시킬 수 있기 때문에 예측 기간 내부의 광범위한 사용과 시장 수요에 기여합니다.
소재별로 보면 수술용 스펀지 시장은 면, 레이온, PVA, 기타 소재로 구분됩니다. 면은 비용 효율적이고 흡수력도 높습니다. 따라서 면은 병원과 외래수술센터(ASC), 특히 대량으로 사용되는 환경에서 최선의 선택입니다. 이러한 요인은이 부문의 성장에 기여합니다.
수술용 스펀지 시장은 모양별로 원형, 원통형, 정사각형, 직사각형 및 기타 모양으로 구분됩니다. 정사각형 및 직사각형 수술용 스펀지는 혈액 및 기타 유체의 효과적인 흡수 및 코팅이 요구되는 다양한 수술 용도에 적합합니다. 이것은 예측 기간 동안 광범위한 채용과 시장 수요에 기여합니다.
최종 사용자별로 수술용 스펀지 시장은 병원 및 외래수술센터(ASC), 전문 클리닉으로 구분됩니다. 특히 신흥 시장에서 헬스케어 인프라의 확대가 병원과 ASC 증가로 이어져 예측기간 동안 이러한 최종사용자의 수술용 스펀지 수요를 견인하고 있습니다.
본 보고서에서는 세계의 수술용 스펀지 시장에 대해 조사했으며, 유형별, 소재별, 형상별, 무균성별, 용도별, 최종 사용자별, 지역별 동향, 시장 진출기업프로파일 등을 정리했습니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 중요 인사이트
제5장 시장 개요
- 소개
- 시장 역학
- 가격 분석
- 밸류체인 분석
- 공급망 분석
- 생태계 분석
- Porter's Five Forces 분석
- 주요 이해관계자와 구매 기준
- 규제 상황
- 무역 분석
- 특허 분석
- 2024-2025년의 주된 회의와 이벤트
- 고객의 비즈니스에 영향을 미치는 동향/혼란
- 투자와 자금조달 시나리오
- 인공지능(AI)이 수술용 스펀지 시장에 미치는 영향
제6장 수술용 스펀지 시장(유형별)
- 소개
- 면 거즈 스펀지
- X선 검출 가능 스펀지
- 부직포 스펀지
- 개복 수술용 스펀지
- 기타
제7장 수술용 스펀지 시장(소재별)
- 소개
- 코튼
- 레이온
- 폴리비닐알코올(PVA)
- 기타
제8장 수술용 스펀지 시장(형상별)
- 소개
- 정사각형 및 직사각형
- 원형 및 원통형
- 기타
제9장 수술용 스펀지 시장(무균성별)
- 소개
- 멸균 수술용 스펀지
- 비멸균 수술용 스펀지
제10장 수술용 스펀지 시장(용도별)
- 소개
- 일반 수술
- 뇌신경외과
- 개복 수술
- 치과 수술
- 이비인후과 수술
- 기타
제11장 수술용 스펀지 시장(최종사용자별)
- 소개
- 병원 및 외래수술센터(ASC)
- 전문 클리닉
제12장 수술용 스펀지 시장(지역별)
- 소개
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
제13장 경쟁 구도
- 개요
- 주요 진입기업의 전략/비책
- 수익 분석
- 시장 점유율 분석
- 기업평가 매트릭스: 주요 진입기업, 2023년
- 기업평가 매트릭스: 스타트업/중소기업, 2023년
- 평가 및 재무 지표
- 브랜드/제품 비교
- 경쟁 시나리오
제14장 기업 프로파일
- 주요 진출기업
- JOHNSON & JOHNSON SERVICES, INC.
- MCKESSON CORPORATION
- CARDINAL HEALTH
- 3M
- INTEGRA LIFESCIENCES CORPORATION
- MEDICOM
- MEDLINE INDUSTRIES, LP.
- DEROYAL INDUSTRIES, INC.
- DUKAL LLC
- DYNAREX CORPORATION
- 기타 기업
- OWENS & MINOR
- ADVACARE PHARMA
- FIRST AID BANDAGE COMPANY
- MOLNLYCKE HEALTH CARE AB
- ALLCARE
- NARANG MEDICAL LIMITED
- AEGIS LIFESCIENCES
- SUNDARAM SURGICAL
- ASPEN SURGICAL PRODUCTS
- OMNI INTERNATIONAL CORP
제15장 부록
JHS
The global surgical sponges market is valued at an estimated 0.81 billion in 2024 and is projected to reach USD 1.19 billion by 2029, at a CAGR of 7.9% during the forecast period. The rise in trauma cases and accidents, as well as the development of the healthcare infrastructure, are the primary drivers of the surgical sponges market's growth. Sterile surgical sponges and other useful surgical supplies are becoming more and more necessary as the frequency of procedures linked to trauma and accidents rises. Therefore, if trauma and accidents become more widespread, there will likely be a greater need for surgical sponges.
| Scope of the Report |
|---|
| Years Considered for the Study | 2022-2029 |
| Base Year | 2023 |
| Forecast Period | 2024-2029 |
| Units Considered | Value (USD Billion) |
| Segments | Type, Material, Shape, Sterility, Application, End User, and Region |
| Regions covered | North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and GCC Countries |
"The x-ray detectable sponges segment is projected to witness highest growth rate in the surgical sponges market, by type, during the forecast period"
Based on type, the surgical sponges market is segmented into x-ray detectable sponges, cotton gauze sponges, laparotomy sponges, nonwoven sponges, and other surgical sponges. The ability of x-ray detectable sponges to significantly enhance patient safety by reducing the risk of retained surgical items by identifying leftover surgical items such as surgical sponges during surgical procedures, contributes to their extensive usage and market demand during the forecast period.
"The cotton segment is projected to witness the highest growth rate in the surgical sponges market, by material, during the forecast period."
Based on material, the surgical sponges market is segmented into cotton, rayon, PVA, and other materials. Cotton is cost-effective, it also have high absorbency, and it is easily available material in most of the regions. Which is making cotton a best choice for hospitals and ambulatory surgical centers, especially in high-volume settings. These factors are contributing to growth of this segment.
"The square & rectangle segment is projected to witness the highest growth rate in the surgical sponges market, in 2023, by shape"
Based on shape, the surgical sponges market is segmented into round & cylindrical, square & rectangle, and other shapes. The square and rectangular shapes make surgical sponges suitable for a range of surgical applications where effective blood and other fluid absorption and coverage are required. Which is contributing to their extensive adoption and market demand during the forecast period.
"The hospitals & ambulatory surgery centers segment is projected to witness the highest growth rate in the surgical sponges market in 2023, by end user".
Based on end users, the surgical sponges market is segmented hospitals & ambulatory surgery centers, and specialty clinics. The expansion of healthcare infrastructure, particularly in emerging markets, has led to an increase in number of hospitals and ASCs, driving demand for surgical sponges among these end users during the forecasted period.
"The Asia Pacific region is projected to witness highest growth rate in the surgical sponges market during the forecast period"
The global surgical sponges market is segmented into six regions - North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. Over the span of the forecast period, the surgical sponges market is expected to grow at the fastest rate in the Asia Pacific region. Over the projected period, the Asia Pacific market is expected to develop at the greatest rate due to factors such government initiatives to raise awareness about illness management and the growing number of hospitals and clinics in China and India.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
- By Designation: C-level - 27%, D-level - 18%, and Others - 55%
- By Region: North America - 35%, Europe - 24%, Asia Pacific - 26%, Latin America - 12%, Middle East & Africa - 2%, and the GCC Countries - 1%
Lists of Companies Profiled in the Report:
Johnson & Johnson Services, Inc. (US), Medline Industries, LP (US), Cardinal Health (US), Integra LifeSciences Corporation (US), Dynarex corporation (US), 3M (US), Medicom (Canada), McKesson Corporation (US), Dukal, LLC (US), DeRoyal Industries, Inc. (US), Owens & Minor Inc. (US), AdvaCare Pharma (US), First aid bandage company (US), AllCare (US), Narang Medical Limited (India), Molnlycke Health Care AB (Sweden), Aegis Lifesciences (India), SUNDARAM SURGICAL (India), Omni International Corp (US), and Aspen Surgical Products, Inc.(US).
Research Coverage:
In this report, the surgical sponges market has been categorized based on material (cotton, rayon, PVA, and other materials), end user (hospitals & ambulatory surgery centers, and specialty clinics), sterility (sterile surgical sponge, and non-sterile surgical sponge), type (x-ray detectable sponges, cotton gauze sponges, laparotomy sponges, nonwoven sponges, and other surgical sponges), application (general surgery, neurosurgery, laparotomy, dental surgery, ENT surgery, and other applications), shape (round & cylindrical, square & rectangle, and other shapes), and region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries).
Comprehensive information regarding the main drivers, barriers, opportunities, and trends influencing the surgical sponges market's expansion is included in detail in this study. An exhaustive study of the key players in the surgical sponges market has been done to provide insights into their business profile, products offered, noteworthy strategies, acquisitions and expansions, and other recent activities pertaining to the market. This study examines the competitive landscape of emerging surgical sponge startups.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall surgical sponges market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, trends, opportunities, and restaints.
The report provides insights on the following pointers:
- Analysis of key drivers: (Rising number of surgical procedures performed, increasing cases of trauma and accidents, growing gearitric population and increasing prevalence of chronic diseases, and growing healthcare infrastructure), restraints (Risk of retained surgical items (RSIs)), opportunities (Increased adoption of outpatient surgeries, and growth opportunities in emerging economies), and trends (Technological advancements in surgical sponges, and developmentand adoption of biodegradable surgical sponges) influencing the growth of the in surgical sponges market.
- Market Development: Comprehensive information about lucrative markets - the report analyses the surgical sponges market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the surgical sponges market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Johnson & Johnson Services, Inc. (US), Cardinal Health (US), and McKesson Corporation (US) are among others, in the surgical sponges market strategies.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Primary sources
- 2.1.2.2 Key data from primary sources
- 2.1.2.3 Key industry insights
- 2.1.2.4 Breakdown of primary interviews
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 BOTTOM-UP APPROACH
- 2.2.1.1 Approach 1: Company revenue estimation approach
- 2.2.2 TOP-DOWN APPROACH
- 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
- 2.4 MARKET SHARE ANALYSIS
- 2.5 STUDY ASSUMPTIONS
- 2.5.1 GROWTH RATE ASSUMPTIONS
- 2.6 RESEARCH LIMITATIONS
- 2.6.1 METHODOLOGY-RELATED LIMITATIONS
- 2.6.2 SCOPE-RELATED LIMITATIONS
- 2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 SURGICAL SPONGES MARKET OVERVIEW
- 4.2 ASIA PACIFIC: SURGICAL SPONGES MARKET, BY TYPE AND COUNTRY (2023)
- 4.3 SURGICAL SPONGES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 4.4 SURGICAL SPONGES MARKET: REGIONAL MIX (2024-2029)
- 4.5 SURGICAL SPONGES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Rising number of surgical procedures performed
- 5.2.1.2 Increasing trauma and accident cases
- 5.2.1.3 Growing geriatric population and increasing prevalence of chronic diseases
- 5.2.1.4 Healthcare infrastructural development and expansion
- 5.2.2 RESTRAINTS
- 5.2.2.1 Risk of retained surgical items
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Growth opportunities in emerging economies
- 5.2.3.2 Increased adoption of outpatient surgeries
- 5.2.4 TRENDS
- 5.2.4.1 Development and adoption of biodegradable surgical sponges
- 5.2.4.2 Technological advancements in surgical sponges
- 5.3 PRICING ANALYSIS
- 5.3.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
- 5.3.2 AVERAGE SELLING PRICE TREND, BY REGION
- 5.4 VALUE CHAIN ANALYSIS
- 5.5 SUPPLY CHAIN ANALYSIS
- 5.6 ECOSYSTEM ANALYSIS
- 5.6.1 SURGICAL SPONGES MARKET: ROLE IN ECOSYSTEM
- 5.7 PORTER'S FIVE FORCES ANALYSIS
- 5.7.1 THREAT OF NEW ENTRANTS
- 5.7.2 THREAT OF SUBSTITUTES
- 5.7.3 BARGAINING POWER OF SUPPLIERS
- 5.7.4 BARGAINING POWER OF BUYERS
- 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.8.2 BUYING CRITERIA
- 5.9 REGULATORY LANDSCAPE
- 5.9.1 NORTH AMERICA
- 5.9.1.1 US
- 5.9.1.2 Canada
- 5.9.2 EUROPE
- 5.9.3 ASIA PACIFIC
- 5.9.3.1 Japan
- 5.9.3.2 China
- 5.9.3.3 India
- 5.9.4 LATIN AMERICA
- 5.9.4.1 Brazil
- 5.9.4.2 Mexico
- 5.9.5 MIDDLE EAST
- 5.9.6 AFRICA
- 5.9.7 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.10 TRADE ANALYSIS
- 5.10.1 IMPORT DATA FOR SURGICAL SPONGES
- 5.10.2 EXPORT DATA FOR SURGICAL SPONGES
- 5.11 PATENT ANALYSIS
- 5.11.1 LIST OF MAJOR PATENTS
- 5.12 KEY CONFERENCES AND EVENTS, 2024-2025
- 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.14 INVESTMENT & FUNDING SCENARIO
- 5.15 IMPACT OF ARTIFICIAL INTELLIGENCE (AI) ON SURGICAL SPONGES MARKET
6 SURGICAL SPONGES MARKET, BY TYPE
- 6.1 INTRODUCTION
- 6.2 COTTON GAUZE SPONGES
- 6.2.1 SUPERIOR PROPERTIES OF COTTON GAUZE TO PROPEL GROWTH
- 6.3 X-RAY-DETECTABLE SPONGES
- 6.3.1 ENHANCED PATIENT SAFETY TO BOOST DEMAND
- 6.4 NONWOVEN SPONGES
- 6.4.1 LINT-FREE NATURE OF NONWOVEN SPONGES TO DRIVE GROWTH
- 6.5 LAPAROTOMY SPONGES
- 6.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET
- 6.6 OTHER SURGICAL SPONGES
7 SURGICAL SPONGES MARKET, BY MATERIAL
- 7.1 INTRODUCTION
- 7.2 COTTON
- 7.2.1 HIGH ABSORBENCY AND WIDE AVAILABILITY TO BOOST MARKET
- 7.3 RAYON
- 7.3.1 EXCEPTIONAL ABSORBENCY AND SOFTNESS TO PROPEL GROWTH
- 7.4 PVA
- 7.4.1 BIOCOMPATIBILITY OF PVA SPONGES TO DRIVE ADOPTION
- 7.5 OTHER MATERIALS
8 SURGICAL SPONGES MARKET, BY SHAPE
- 8.1 INTRODUCTION
- 8.2 SQUARE & RECTANGLE
- 8.2.1 ADAPTABILITY AND WIDE USE TO BOOST MARKET GROWTH
- 8.3 ROUND & CYLINDRICAL
- 8.3.1 PRECISION AND EASE OF MAINTAINING PATIENT SAFETY TO DRIVE MARKET
- 8.4 OTHER SHAPES
9 SURGICAL SPONGES MARKET, BY STERILITY
- 9.1 INTRODUCTION
- 9.2 STERILE SURGICAL SPONGES
- 9.2.1 EMPHASIS ON INFECTION CONTROL AND PREVENTION IN HEALTHCARE SETTINGS TO PROMOTE MARKET GROWTH
- 9.3 NON-STERILE SURGICAL SPONGES
- 9.3.1 WIDE USE IN CLEANING WOUNDS AND DRESSING MINOR INJURIES TO PROPEL GROWTH
10 SURGICAL SPONGES MARKET, BY APPLICATION
- 10.1 INTRODUCTION
- 10.2 GENERAL SURGERY
- 10.2.1 RISING NUMBER OF HERNIA REPAIR PROCEDURES TO DRIVE MARKET
- 10.3 NEUROSURGERY
- 10.3.1 GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH
- 10.4 LAPAROTOMY
- 10.4.1 RISING NUMBER OF LAPAROTOMY PROCEDURES WORLDWIDE TO DRIVE MARKET
- 10.5 DENTAL SURGERY
- 10.5.1 RISING PREVALENCE OF ORAL DISEASES AND GROWING AWARENESS OF DENTAL CARE TO DRIVE GROWTH
- 10.6 ENT SURGERY
- 10.6.1 INCREASING DISPOSABLE INCOME AND AFFORDABILITY TO BOOST GROWTH
- 10.7 OTHER APPLICATIONS
11 SURGICAL SPONGES MARKET, BY END USER
- 11.1 INTRODUCTION
- 11.2 HOSPITALS & AMBULATORY SURGERY CENTERS
- 11.2.1 RISING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS IN HEALTHCARE TO PROMOTE MARKET GROWTH
- 11.3 SPECIALTY CLINICS
- 11.3.1 GROWING NUMBER OF SURGERIES TO DRIVE MARKET
12 SURGICAL SPONGES MARKET, BY REGION
- 12.1 INTRODUCTION
- 12.2 NORTH AMERICA
- 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 12.2.2 US
- 12.2.2.1 Strong healthcare infrastructure to support market growth
- 12.2.3 CANADA
- 12.2.3.1 Growing geriatric population and increasing volume of surgeries to drive demand
- 12.3 EUROPE
- 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPEAN UNION
- 12.3.2 GERMANY
- 12.3.2.1 Increasing healthcare expenditure and rising per capita disposable income to propel market
- 12.3.3 UK
- 12.3.3.1 Growing volume of cardiovascular surgeries to drive market
- 12.3.4 FRANCE
- 12.3.4.1 Presence of robust healthcare systems to augment market
- 12.3.5 ITALY
- 12.3.5.1 Rising geriatric population and increasing number of chronic diseases to support market
- 12.3.6 SPAIN
- 12.3.6.1 Growing demand for effective surgical outcomes to create major growth opportunities
- 12.3.7 REST OF EUROPE
- 12.4 ASIA PACIFIC
- 12.4.1 MACROECONOMIC OUTLOOK FOR EAST ASIA & PACIFIC
- 12.4.2 CHINA
- 12.4.2.1 Rising number of hospitals and greater public access to modern healthcare to drive market
- 12.4.3 JAPAN
- 12.4.3.1 Rising prevalence of chronic diseases and robust healthcare system to support market
- 12.4.4 INDIA
- 12.4.4.1 Large patient population and developing healthcare sector to drive market
- 12.4.5 REST OF ASIA PACIFIC
- 12.5 LATIN AMERICA
- 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA & CARIBBEAN
- 12.5.2 BRAZIL
- 12.5.2.1 Increasing cases of accidents and traumas to fuel market
- 12.5.3 MEXICO
- 12.5.3.1 Low-cost surgeries and enhanced healthcare infrastructure to aid market
- 12.5.4 REST OF LATIN AMERICA
- 12.6 MIDDLE EAST & AFRICA
- 12.6.1 INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET
- 12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & NORTH AFRICA
- 12.7 GCC COUNTRIES
- 12.7.1 ADVANCEMENTS AND INCREASED GOVERNMENT INVESTMENTS IN HEALTHCARE SECTOR TO PROPEL MARKET
- 12.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
13 COMPETITIVE LANDSCAPE
- 13.1 OVERVIEW
- 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 13.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN SURGICAL SPONGES MARKET
- 13.3 REVENUE ANALYSIS
- 13.4 MARKET SHARE ANALYSIS
- 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 13.5.1 STARS
- 13.5.2 EMERGING LEADERS
- 13.5.3 PERVASIVE PLAYERS
- 13.5.4 PARTICIPANTS
- 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 13.5.5.1 Company footprint
- 13.5.5.2 Type footprint
- 13.5.5.3 Material footprint
- 13.5.5.4 Shape footprint
- 13.5.5.5 Sterility footprint
- 13.5.5.6 Application footprint
- 13.5.5.7 End-user footprint
- 13.5.5.8 Region footprint
- 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 13.6.1 PROGRESSIVE COMPANIES
- 13.6.2 STARTING BLOCKS
- 13.6.3 RESPONSIVE COMPANIES
- 13.6.4 DYNAMIC COMPANIES
- 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
- 13.7 VALUATION & FINANCIAL METRICS
- 13.8 BRAND/PRODUCT COMPARISON
- 13.9 COMPETITIVE SCENARIO
- 13.9.1 DEALS
- 13.9.2 EXPANSIONS
- 13.9.3 OTHER DEVELOPMENTS
14 COMPANY PROFILES
- 14.1 KEY PLAYERS
- 14.1.1 JOHNSON & JOHNSON SERVICES, INC.
- 14.1.1.1 Business overview
- 14.1.1.2 Products offered
- 14.1.1.3 MnM view
- 14.1.1.3.1 Right to win
- 14.1.1.3.2 Strategic choices
- 14.1.1.3.3 Weaknesses & competitive threats
- 14.1.2 MCKESSON CORPORATION
- 14.1.2.1 Business overview
- 14.1.2.2 Products offered
- 14.1.2.3 MnM view
- 14.1.2.3.1 Key strengths
- 14.1.2.3.2 Strategic choices
- 14.1.2.3.3 Weaknesses and competitive threats
- 14.1.3 CARDINAL HEALTH
- 14.1.3.1 Business overview
- 14.1.3.2 Products offered
- 14.1.3.3 MnM view
- 14.1.3.3.1 Key strengths
- 14.1.3.3.2 Strategic choices
- 14.1.3.3.3 Weaknesses and competitive threats
- 14.1.4 3M
- 14.1.4.1 Business overview
- 14.1.4.2 Products offered
- 14.1.4.3 Recent developments
- 14.1.4.3.1 Other developments
- 14.1.4.4 MnM view
- 14.1.4.4.1 Key strengths
- 14.1.4.4.2 Strategic choices
- 14.1.4.4.3 Weaknesses and competitive threats
- 14.1.5 INTEGRA LIFESCIENCES CORPORATION
- 14.1.5.1 Business overview
- 14.1.5.2 Products offered
- 14.1.5.3 Recent developments
- 14.1.6 MEDICOM
- 14.1.6.1 Business overview
- 14.1.6.2 Products offered
- 14.1.7 MEDLINE INDUSTRIES, LP.
- 14.1.7.1 Business overview
- 14.1.7.2 Product offered
- 14.1.7.3 Recent developments
- 14.1.8 DEROYAL INDUSTRIES, INC.
- 14.1.8.1 Business overview
- 14.1.8.2 Product offered
- 14.1.9 DUKAL LLC
- 14.1.9.1 Business overview
- 14.1.9.2 Product offered
- 14.1.10 DYNAREX CORPORATION
- 14.1.10.1 Business overview
- 14.1.10.2 Product offered
- 14.2 OTHER PLAYERS
- 14.2.1 OWENS & MINOR
- 14.2.2 ADVACARE PHARMA
- 14.2.3 FIRST AID BANDAGE COMPANY
- 14.2.4 MOLNLYCKE HEALTH CARE AB
- 14.2.5 ALLCARE
- 14.2.6 NARANG MEDICAL LIMITED
- 14.2.7 AEGIS LIFESCIENCES
- 14.2.8 SUNDARAM SURGICAL
- 14.2.9 ASPEN SURGICAL PRODUCTS
- 14.2.10 OMNI INTERNATIONAL CORP
15 APPENDIX
- 15.1 DISCUSSION GUIDE
- 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 15.3 CUSTOMIZATION OPTIONS
- 15.4 RELATED REPORTS
- 15.5 AUTHOR DETAILS
